Product Information
TACROLIMUS 0.03% OINTMENT is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.7954 per GM under NDC 00168041799. Its NADAC has been published 536 times since Feb 18, 2015.
FDA first approved this application on Sep 9, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/g
NDC
00168041799
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA200744FDA Approved
9/9/2014
TE Code
AB
On Market Since
9/9/2014
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.03% OINTMENT has been published 536 times since Feb 18, 2015, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7954 per GM |
|---|---|
| All-time high | $6.1613 (Jun 15, 2016) |
| All-time low | $0.5757 (Apr 22, 2026) |
| 52-week high | $0.7954 |
| 52-week low | $0.5757 |
| Median price | $2.6043 |
| Average price | $3.0505 |
| Largest weekly change | +75.9% (Jan 18, 2023) |
| Weeks tracked | 536 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.03% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.7954 per GM (NDC 00168041799), effective Aug 19, 2026.
How has the price of TACROLIMUS 0.03% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 86.3%. It has been tracked across 536 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?
Since Feb 18, 2015, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.5757 (Apr 22, 2026) to a high of $6.1613 (Jun 15, 2016), with a median of $2.6043 per GM.
Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TACROLIMUS 0.03% OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures TACROLIMUS 0.03% OINTMENT?
TACROLIMUS 0.03% OINTMENT (NDC 00168041799) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.